Targeted Cancer Diagnostic and Therapeutic Agents: Delivery by Carriers or Conjugation

Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 47

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_REMJ-4-3_002

تاریخ نمایه سازی: 22 دی 1402

Abstract:

Receptors and proteins are overexpressed in many human cancer cell membranes rather than normal tissues and are considered as the main molecular targets. Specific tumor- targeting molecules which have high affinity for these receptors can be valuable tools as carrier molecules for targeted cancer therapy and imaging. Pharmacokinetics and bioavailability of diagnostic and therapeutic agents are very important. Poor selectivity of cancer therapeutic agents causes toxicity on normal cells that limits maximum effective dose. The Attachment of these agents to macromolecules or their installation on carriers is currently under investigation. This article presents recent developments in the field of targeting agents and introduces different carriers and their applications in the diagnosis and treatment of cancer.

Authors

Mohsen Mohammadgholi

PhD Student of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

Farzaneh Rezazadeh

PhD Student of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

Nourollah Sadeghzadeh

Assistant Professor of Radiopharmacy Science, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Aerts A, Impens NREN, Gijs M, D'Huyvetter M, Vanmarcke H, ...
  • Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. J. ...
  • Chopra D. Radiolabelled Nanoparticles for Diagnosis and Treatment of Cancer: ...
  • Kumar SR, Deutscher SL. ۱۱۱In-labeled galectin-۳-targeting peptide as a SPECT ...
  • Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, ...
  • Sudimack J, Lee RJ. Targeted drug delivery via the folate ...
  • Van de Wiele C, Dumont F, Dierckx RA, Peers SH, ...
  • Li L, Wartchow CA, Danthi SN, Shen Z, Dechene N, ...
  • Kim E-M, Joung M-H, Lee C-M, Jeong H-J, Lim ST, ...
  • Fahmy TM, Fong PM, Goyal A, Saltzman WM. Targeted for ...
  • Tani Y, Nakajima M, Kikuchi M, Ihara K, Muroi H, ...
  • Fujii T, Yajima R, Tatsuki H, Oosone K, Kuwano H. ...
  • Lambert JM. Drug-conjugated monoclonal antibodies for the treatment of cancer. ...
  • Harris M. Monoclonal antibodies as therapeutic agents for cancer. Lancet ...
  • Teicher BA, Chari RVJ. Antibody conjugate therapeutics: challenges and potential. ...
  • Alley SC, Okeley NM, Senter PD. Antibody-drug conjugates: targeted drug ...
  • Senter PD, Springer CJ. Selective activation of anticancer prodrugs by ...
  • Hamblett KJ, Senter PD, Chace DF, Sun MMC, Lenox J, ...
  • Kuroda K, Liu H, Kim S, Guo M, Navarro V, ...
  • Wang S, Noberini R, Stebbins JL, Das S, Zhang Z, ...
  • Cheng WW, Allen TM. The use of single chain Fv ...
  • Ray P, White RR. Aptamers for targeted drug delivery. Pharmaceuticals ...
  • Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, ...
  • Bagalkot V, Farokhzad OC, Langer R, Jon S. An Aptamer-Doxorubicin ...
  • Huang YF, Shangguan D, Liu H, Phillips JA, Zhang X, ...
  • Hao Z, Fan W, Hao J, Wu X, Zeng GQ, ...
  • Hicke BJ, Stephens AW, Gould T, Chang Y-F, Lynott CK, ...
  • Mansi R, Fleischmann A, Mäcke HR, Reubi JC. Targeting GRPR ...
  • Fani M, Maecke HR, Okarvi SM. Radiolabeled peptides: valuable tools ...
  • Khan IU, Zwanziger D, Böhme I, Javed M, Naseer H, ...
  • van Hensbergen Y, Broxterman HJ, Elderkamp YW, Lankelma J, Beers ...
  • Ranieri G, Patruno R, Ruggieri E, Montemurro S, Valerio P, ...
  • Askoxylakis V, Zitzmann S, Mier W, Graham K, Krämer S, ...
  • Lu Z-R, Shiah J-G, Sakuma S, Kopečková P, Kopeček J. ...
  • Torchilin VP, Lukyanov AN. Peptide and protein drug delivery to ...
  • Chau Y, Padera RF, Dang NM, Langer R. Antitumor efficacy ...
  • Xiong X-B, Huang Y, Lu W-L, Zhang X, Zhang H, ...
  • Lu R-M, Chen M-S, Chang D-K, Chiu C-Y, Lin W-C, ...
  • Li Z-B, Wu Z, Chen K, Ryu EK, Chen X. ...
  • Sadeghzadeh N, Gandomkar M, Shafiee M, Mazidi M, Goudarzi M, ...
  • Sadeghzadeh N, Gandomkar M, Najafi R, Shafiei M, Ebrahimi SES, ...
  • King R, Surfraz MB-U, Finucane C, Biagini SCG, Blower PJ, ...
  • Tsiapa I, Loudos G, Varvarigou A, Fragogeorgi E, Psimadas D, ...
  • Ting G, Chang C-H, Wang H-E. Cancer nanotargeted radiopharmaceuticals for ...
  • Barenholz YC. Doxil®-the first FDA-approved nano-drug: lessons learned. J. Controlled ...
  • Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F. ...
  • Patil R, Portilla-Arias J, Ding H, Konda B, Rekechenetskiy A, ...
  • Brown SD, Nativo P, Smith J-A, Stirling D, Edwards PR, ...
  • Drummond DC, Noble CO, Guo Z, Hayes ME, Connolly-Ingram C, ...
  • Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer ...
  • Chanda N, Kattumuri V, Shukla R, Zambre A, Katti K, ...
  • Navarro G, Cabral P, Cabrera M, Fernández M, Gambini JP, ...
  • Bao A, Goins B, Klipper R, Negrete G, Phillips WT. ...
  • Kim S, Kim D, Jung HH, Lee I-H, Kim JIL, ...
  • Kaspar M, Zardi L, Neri D. Fibronectin as target for ...
  • Nilsson F, Kosmehl H, Zardi L, Neri D. Targeted delivery ...
  • Passarella RJ, Zhou L, Phillips JG, Wu H, Hallahan DE, ...
  • Kim H, Lee Y, Lee I-H, Kim S, Kim D, ...
  • Park J, Park S, Kim S, Lee I-H, Saw PE, ...
  • نمایش کامل مراجع